$Eton Pharmaceutical (ETON.US)$Eton Pharmaceuticals Acquires Exclusive U.S. Rights To PKU GOLIKE From Relief Therapeutics, Expects To Be Accretive To Earnings In 2024 Moomoo 24/7· 02:29 Eton Pharmaceutical PKU GOLIKE is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call point Transaction is expected to be accretive to 2024 earnings Estimated peak sales of more than $10 million annually U.S. phenylketonuria ("PKU") medical formula market estimated to be $100 million annually
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
73168262 : And yet very little volume